Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) — Stock Score Summary

Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) has a MoatMap StockRank of 20/100 based on Quality (36/100), Value (27/100), and Momentum (44/100) factor scores. The current signal is SELL. Zhejiang Hisoar Pharmaceutical is a Chinese API and CDMO player. While it operates in the CDMO space, geopolitical tensions and supply chain localization initiatives (such as the US Biosecure Act) present severe headwinds for Chinese CDMOs serving Western markets.

Zhejiang Hisoar Pharmaceutical Co., Ltd. manufactures active pharmaceutical ingredients (APIs), specialty chemicals, and finished dosage forms, focusing on antibiotics and cardiovascular drugs. The company is a key global supplier of APIs, maintaining long-term contract manufacturing (CDMO) partnerships with multinational pharmaceutical giants. Its competitive moat is built on stringent international quality certifications (FDA, CEP) and advanced chemical synthesis capabilities.

Key Financial Metrics

Price$0.78
Market Cap$1.3B
P/E (Forward)17.47
Price/Book1.77
Return on Equity-1.5%
Return on Invested Capital-1.1%
Debt/Equity22.23
Gross Margin19.9%
Operating Margin3.2%
Revenue Growth0.0%
Free Cash Flow$2M

Zhejiang Hisoar Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Zhejiang Hisoar Pharmaceutical Co., Ltd.’s (002099.SZ) StockRank?
MoatMap’s StockRank for Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) is 20/100, with a Sell signal. It is a composite of Quality (36), Value (27), and Momentum (44) factor ranks across MoatMap’s 19,000+ stock universe.
Does Zhejiang Hisoar Pharmaceutical Co., Ltd. have an economic moat?
Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) has a Quality factor score of 36/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Zhejiang Hisoar Pharmaceutical Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) is Sell, based on a StockRank of 20/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Zhejiang Hisoar Pharmaceutical Co., Ltd. in?
Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).
Browse all ranked stocks002099.SZ deep dive reportAI ChampionsHow we score stocksSense-check another stock